David Shaywitz
@dshaywitz.bsky.social
Biology-grounded MD/PhD exec | Healthy aging & flourishing at scale | Evidence-based medicine x lifestyle × tech | Agency as engine of change | Strategic Advisor | Writer | kindwellhealth.com
2/3 This is the mental model I have for flourishing health; mostly, health platforms tend to focus on just the bottom third, essentially biometrics, and need to enlarge their approach to cultivate agency and encourage engagement and real-world connection. @angeladuckworth.bsky.social
November 13, 2025 at 5:19 PM
2/3 This is the mental model I have for flourishing health; mostly, health platforms tend to focus on just the bottom third, essentially biometrics, and need to enlarge their approach to cultivate agency and encourage engagement and real-world connection. @angeladuckworth.bsky.social
Hi - I'm not an expert on this subject and wouldn't pretend to offer medical advice on this deeply personal topic - but below is the reason offered by @openevidence.bsky.social for the change...
November 11, 2025 at 1:52 PM
Hi - I'm not an expert on this subject and wouldn't pretend to offer medical advice on this deeply personal topic - but below is the reason offered by @openevidence.bsky.social for the change...
Also on positive impact of estrogen on postmenopausal women, my mom published this study 2003: journals.lww.com/menopausejou...
November 11, 2025 at 1:42 PM
Also on positive impact of estrogen on postmenopausal women, my mom published this study 2003: journals.lww.com/menopausejou...
Fun share, Eric! Not only interesting (& reassuring to many), but also part of the process of science-&, as the saying goes, why we do the experiment.
Here's a slide to this point I often include on talks on innovation and digital health - includes several prominent/classic egs from cardiology...
Here's a slide to this point I often include on talks on innovation and digital health - includes several prominent/classic egs from cardiology...
November 9, 2025 at 3:40 PM
Fun share, Eric! Not only interesting (& reassuring to many), but also part of the process of science-&, as the saying goes, why we do the experiment.
Here's a slide to this point I often include on talks on innovation and digital health - includes several prominent/classic egs from cardiology...
Here's a slide to this point I often include on talks on innovation and digital health - includes several prominent/classic egs from cardiology...
Late in the season but still the occasional breathtaking beauty…
November 5, 2025 at 2:16 PM
Late in the season but still the occasional breathtaking beauty…
"Everyone has won and all must have prizes."
- The Dodo
- The Dodo
October 31, 2025 at 3:47 PM
"Everyone has won and all must have prizes."
- The Dodo
- The Dodo
Latest TR on intersection of 2 topics: underappreciated importance of social connection as key driver of longevity & increased availability of easy-to-apply tools to assess "biological" aging: timmermanreport.com/2025/10/the-.... Bottom line ⬇️. @alicecallahan.bsky.social @sarahlongwell25.bsky.social
October 24, 2025 at 9:00 PM
Latest TR on intersection of 2 topics: underappreciated importance of social connection as key driver of longevity & increased availability of easy-to-apply tools to assess "biological" aging: timmermanreport.com/2025/10/the-.... Bottom line ⬇️. @alicecallahan.bsky.social @sarahlongwell25.bsky.social
This LI post, summarizing recent panel discussion about AI in biopharma, triggered me b/c it seemed absolutely unmoored from reality. In particular, idea that "biotech now calculates success like NASA, not 'shots on goal'"= total fantasy. www.linkedin.com/posts/aaronb... @matthewherper.bsky.social
October 23, 2025 at 11:38 AM
This LI post, summarizing recent panel discussion about AI in biopharma, triggered me b/c it seemed absolutely unmoored from reality. In particular, idea that "biotech now calculates success like NASA, not 'shots on goal'"= total fantasy. www.linkedin.com/posts/aaronb... @matthewherper.bsky.social
The beauty of autumn in New England
October 22, 2025 at 1:13 PM
The beauty of autumn in New England
Final graf in my new @wsj.com book review of "Why Brains Need Friends," on the neuroscience+health value of social connection. www.wsj.com/arts-culture...
@nachristakis.bsky.social @dereklowe.bsky.social @euanashley.bsky.social @thgoetz.bsky.social @hannahkuchler.bsky.social @jvl.bsky.social
@nachristakis.bsky.social @dereklowe.bsky.social @euanashley.bsky.social @thgoetz.bsky.social @hannahkuchler.bsky.social @jvl.bsky.social
October 13, 2025 at 8:26 PM
Final graf in my new @wsj.com book review of "Why Brains Need Friends," on the neuroscience+health value of social connection. www.wsj.com/arts-culture...
@nachristakis.bsky.social @dereklowe.bsky.social @euanashley.bsky.social @thgoetz.bsky.social @hannahkuchler.bsky.social @jvl.bsky.social
@nachristakis.bsky.social @dereklowe.bsky.social @euanashley.bsky.social @thgoetz.bsky.social @hannahkuchler.bsky.social @jvl.bsky.social
Who knew?
Happy autumn!
Happy autumn!
October 11, 2025 at 4:58 PM
Who knew?
Happy autumn!
Happy autumn!
Move over Peter Attia and @hubermanlab.com -- looks like @zekeemanuel.bsky.social is leaping (energetically...) into the wellness influencer space! LI announcement ->
linkedin.com/posts/zeke-e...
cc @erictopol.bsky.social @alicecallahan.bsky.social @euanashley.bsky.social
linkedin.com/posts/zeke-e...
cc @erictopol.bsky.social @alicecallahan.bsky.social @euanashley.bsky.social
September 18, 2025 at 7:11 PM
Move over Peter Attia and @hubermanlab.com -- looks like @zekeemanuel.bsky.social is leaping (energetically...) into the wellness influencer space! LI announcement ->
linkedin.com/posts/zeke-e...
cc @erictopol.bsky.social @alicecallahan.bsky.social @euanashley.bsky.social
linkedin.com/posts/zeke-e...
cc @erictopol.bsky.social @alicecallahan.bsky.social @euanashley.bsky.social
Wisdom bombs on AI and informatics from the inimitable Zak Kohane @harvardmed.bsky.social - always elevating, often sobering, invariably humane.
September 16, 2025 at 4:23 PM
Wisdom bombs on AI and informatics from the inimitable Zak Kohane @harvardmed.bsky.social - always elevating, often sobering, invariably humane.
and I also worry about impact on attracting future talent to the industry, as noted here
September 16, 2025 at 12:24 PM
and I also worry about impact on attracting future talent to the industry, as noted here
Can't tell you how often I'm hearing this...
September 16, 2025 at 12:24 PM
Can't tell you how often I'm hearing this...
@simonbayly.bsky.social while I wouldn't want to carry comparison too far, in some ways (& perhaps this is intentional from an Administration keen to punish pointed-head elites) this feels like white collar version of blue collar despair Springsteen & others describe-just change a few words...
September 16, 2025 at 12:11 PM
@simonbayly.bsky.social while I wouldn't want to carry comparison too far, in some ways (& perhaps this is intentional from an Administration keen to punish pointed-head elites) this feels like white collar version of blue collar despair Springsteen & others describe-just change a few words...
Saw this on my Peloton this am, reinforced idea of real fitness->longevity pivot, as I recently discussed in @bostonglobe.com drive.google.com/file/d/1rfga.... There are good data behind lifestyle interventions, but health/flourishing=more than performance metrics: also connection, purpose, agency.
September 14, 2025 at 11:45 AM
Saw this on my Peloton this am, reinforced idea of real fitness->longevity pivot, as I recently discussed in @bostonglobe.com drive.google.com/file/d/1rfga.... There are good data behind lifestyle interventions, but health/flourishing=more than performance metrics: also connection, purpose, agency.
4/4 Delighted to see this callout, emphasizing strong evidence base for lifestyle interventions, an area I've been emphasizing and where I see tremendous near-term tech-enabled opportunity, building on scaled products eg Tonal, WHOOP, Peloton, Oura -> kindwellhealth.com/reading-reso....
September 13, 2025 at 10:22 AM
4/4 Delighted to see this callout, emphasizing strong evidence base for lifestyle interventions, an area I've been emphasizing and where I see tremendous near-term tech-enabled opportunity, building on scaled products eg Tonal, WHOOP, Peloton, Oura -> kindwellhealth.com/reading-reso....
3/4 While not focus of report, McK does explicitly speak to need for healthcare practitioners to focus more on healthcare vs sick care - a familiar call and certainly what a number of motivated consumers are already seeking (caveat emptor).
September 13, 2025 at 10:22 AM
3/4 While not focus of report, McK does explicitly speak to need for healthcare practitioners to focus more on healthcare vs sick care - a familiar call and certainly what a number of motivated consumers are already seeking (caveat emptor).
2/4 Figure/heatmap from McK report, relating geroscience framework, "hallmarks of aging," to biopharma TAs, essentially.
September 13, 2025 at 10:22 AM
2/4 Figure/heatmap from McK report, relating geroscience framework, "hallmarks of aging," to biopharma TAs, essentially.
Love this graf from @katieroiphe.bsky.social @wsj.com piece on what she took away from getting into strength training; for one: enhanced sense of agency. wsj.com/lifestyle/fitn…
For more on agency & health, I’ve organized a few useful resources here: kindwellhealth.com/reading-resour���
For more on agency & health, I’ve organized a few useful resources here: kindwellhealth.com/reading-resour���
September 13, 2025 at 1:37 AM
Love this graf from @katieroiphe.bsky.social @wsj.com piece on what she took away from getting into strength training; for one: enhanced sense of agency. wsj.com/lifestyle/fitn…
For more on agency & health, I’ve organized a few useful resources here: kindwellhealth.com/reading-resour���
For more on agency & health, I’ve organized a few useful resources here: kindwellhealth.com/reading-resour���
4/4 I argue many of the AI implementation challenges experienced by biopharma in early days reflects an ill-conceived drive to push/jam AI into the org to achieve anticipated (but generally illusory) productivity gains; I favor a "pull" approach driven by motivated lead users.
September 11, 2025 at 11:38 PM
4/4 I argue many of the AI implementation challenges experienced by biopharma in early days reflects an ill-conceived drive to push/jam AI into the org to achieve anticipated (but generally illusory) productivity gains; I favor a "pull" approach driven by motivated lead users.
3/4 The most successful AI tools seem narrowly tailored to specific processes, to opportunities that I've been calling "pockets of reducibility," borrowing the memorable phrase coined by @stephenwolfram.bsky.social
September 11, 2025 at 11:38 PM
3/4 The most successful AI tools seem narrowly tailored to specific processes, to opportunities that I've been calling "pockets of reducibility," borrowing the memorable phrase coined by @stephenwolfram.bsky.social
2/4 @newyorker.com economics writer @johncassidysays.bsky.social nicely reviews what's meant by the "productivity paradox," a phenomenon described for computers in 1987, and now recurring in context of AI...
September 11, 2025 at 11:38 PM
2/4 @newyorker.com economics writer @johncassidysays.bsky.social nicely reviews what's meant by the "productivity paradox," a phenomenon described for computers in 1987, and now recurring in context of AI...